AstraZeneca PLC
Stock Details
Is it expensive?
Market Cap
287.95B
Trailing P/E Ratio
27.95
Forward P/E Ratio
23.10
PEG Ratio
4.78
313.48B
15.65
Price-to-Sales (TTM)
4.76
6.07
30.56
Is it profitable?
60.44B
Net Profit Margin (TTM)
17.19%
Gross Profit Margin
82.48%
Diluted EPS (TTM)
6.63
23.48%
Is it growing?
12.50%
5.60%
Is it risky?
0.22
71.82
34.03B
0.91
Who owns it?
65.02%
0.05%
0.14%
1.55B
1.54B
Does it pay?
2.32%
47.70%
Aug 15, 2024
Sep 9, 2024
How much cash?
7.67B
14.22B
6.56B
4.96
- Price
- 185.73
- Percent Change
- +0.40 (0.21%)
- Previous Close
- 185.33
- Open
- 186.04
- Low
- 184.65
- High
- 186.90
52-Week Range Position (52WRP)
Above Average
Above Average
within its 1-year price range
$185.73
From 52W Low
+35.35%
From 52W High
-12.69%
Today
+0.21%
1Y Change
+27.51%
6M
$181.04
3M
$203.73
1M
$187.37
Today
$185.73
From 52W Low
+35.35%
From 52W High
-12.69%
Today
+0.21%
1Y Change
+27.51%
6M
$181.04
3M
$203.73
1M
$187.37
Today
$185.73
Above Average
within its 1-year price range
$185.73
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-0.9%
3M
-8.8%
6M
+2.6%
1Y
+27.5%
Rate of Change (ROC)
Accelerating
Price is falling 8.8x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- AstraZeneca PLC
- Founded
- 1992
- CEO
- Pascal Claude Roland Soriot
- Employees
- 94,300
- Fiscal Year End
- Dec 31, 2024
- Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Pharmaceuticals
- Website
- www.astrazeneca.com
Indicators
Operating Cash Flow
14.22B
Net Income
10.39B
Real Earnings
1.37
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
14.22B
Net Income
10.39B
Real Earnings
1.37
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Market Cap
287.95B
Trailing P/E Ratio
27.95
Forward P/E Ratio
23.10
PEG Ratio
4.78
313.48B
15.65
Price-to-Sales (TTM)
4.76
6.07
30.56
Is it profitable?
60.44B
Net Profit Margin (TTM)
17.19%
Gross Profit Margin
82.48%
Diluted EPS (TTM)
6.63
23.48%
Is it growing?
12.50%
5.60%
Is it risky?
0.22
71.82
34.03B
0.91
Who owns it?
65.02%
0.05%
0.14%
1.55B
1.54B
Does it pay?
2.32%
47.70%
Aug 15, 2024
Sep 9, 2024
How much cash?
7.67B
14.22B
6.56B
4.96
- Price
- 185.73
- Percent Change
- +0.40 (0.21%)
- Previous Close
- 185.33
- Open
- 186.04
- Low
- 184.65
- High
- 186.90
52-Week Range Position (52WRP)
Above Average
Above Average
within its 1-year price range
$185.73
From 52W Low
+35.35%
From 52W High
-12.69%
Today
+0.21%
1Y Change
+27.51%
6M
$181.04
3M
$203.73
1M
$187.37
Today
$185.73
From 52W Low
+35.35%
From 52W High
-12.69%
Today
+0.21%
1Y Change
+27.51%
6M
$181.04
3M
$203.73
1M
$187.37
Today
$185.73
Above Average
within its 1-year price range
$185.73
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-0.9%
3M
-8.8%
6M
+2.6%
1Y
+27.5%
Rate of Change (ROC)
Accelerating
Price is falling 8.8x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- AstraZeneca PLC
- Founded
- 1992
- CEO
- Pascal Claude Roland Soriot
- Employees
- 94,300
- Fiscal Year End
- Dec 31, 2024
- Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Pharmaceuticals
- Website
- www.astrazeneca.com